logo

 

MIRA INFORM REPORT

 

 

Report Date :            

09.04.2011

 

IDENTIFICATION DETAILS

 

Name :

THE SCHAZOO LABORATORIES (PVT) LIMITED

 

 

Registered Office :

Schazoo House, 45-G.T. Road, Lahore

 

 

Country :

Pakistan

 

 

Financials (as on) :

30.06.2008

 

 

Year of Establishment :

1952

 

 

Com. Reg. No.:

0000507

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Manufacture & Marketing of Pharmaceutical Products

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 31, 2010

 

Country Name

Previous Rating

                   (30.09.2010)                  

Current Rating

(31.12.2010)

Pakistan

b2

b2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

                                   

Business Name

 

THE SCHAZOO LABORATORIES (PVT) LIMITED

 

 

Full Address       

 

Registered Address & Factory

Schazoo House, 45-G.T. Road, Lahore, Pakistan

                       

Tel #

92 (42) 111-666-600, 36818450, 36856631, 36841003

Fax #

92 (42) 36856631

Email

mail@schazoo.com,

schazoo@paknet.ptc.pk

 

 

Short Description Of Business

 

a.

Nature of Business       

Manufacture & Marketing of Pharmaceutical Products

b.

Year Established

1952

c.

Registration #

0000507

 

 

Factory Location

 

Kalalwala, 20 km-Lahore-Jaranwala Road,

District Sheikhupura, Punjab, Pakistan

 

 

Auditors

 

A. Aziz Chaudhry & Co.

(Chartered Accountants)

38, Shahrah-e-Quaid-e-Azam, Lahore, Pakistan

 

 

Legal Status

 

Subject Company was established as a Private Limited Company in 1952

 

 

Authorized Capital    

Rs. 9,900,000/- divided into 99,000 shares of Rs. 100/- each

Issued & Paid up Capital

Rs. 9,507,000/- divided into 95,070 shares of Rs. 100/- each

 

 

Details of Chief Executive/ Directors

 

Names

Nationality

Address

Occupation

Designation

Mr. Mohammed Zaka-Ur-Rehman

 

Begum Almas

Parveen

 

 

Mr. Ahmad Zaka-Ur-Rehman

 

 

Mr. Ahmed Shuja-Ur-Rehman

 

 

Mr. Asad Shuja-Ur-Rehman

 

 

Mr. Mujtaba Shuja-Ur-Rahman

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

Schazoo House, 45-G.T. Road, Lahore

 

Schazoo House, 45-G.T. Road, Lahore

 

Schazoo House, 45-G.T. Road, Lahore

 

Schazoo House, 45-G.T. Road, Lahore

 

Schazoo House, 45-G.T. Road, Lahore

 

Schazoo House, 45-G.T. Road, Lahore

Business

 

 

 

Business

 

 

 

Business

 

 

 

Business

 

 

 

Business

 

 

 

Business

Chief Executive

 

 

 

Director

 

 

 

Director

 

 

 

Director

 

 

 

Director

 

 

 

Director

 

 

Shareholders                

 

Names

No. of Shares

Begum Almas Parveen

 

Mrs. Aasia Saail Khan

 

Mr. Ahmad Zaka-Ur-Rehman

 

Mr. Asad Shuja-Ur-Rehman

 

Mr. Mohammed Zaka-Ur-Rehman

 

Mr. A. Qayum Namdar

 

Mr. Mujtaba Shuja-Ur-Rahman

 

Mrs. Samira Shahzad

 

Begum Yasmin M. Rehman

 

Mrs. Farrah Nadeem K. Haq

 

Al-Haj Moulana Mian Ghulam Qadir & Nazir Begum Memorial Trust

 

Mrs. Zeba Ahmad Shuja

 

Mrs. Bushra M. Zaka

 

Mr. Ahmed Shuja-Ur-Rehman

30,979

 

1,575

 

3,149

 

13,351

 

5,640

 

156

 

13,351

 

1,575

 

1,587

 

6,049

 

 

433

 

1,575

 

2,454

 

13,196

 

 

Associates                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

 

A.         Subsidiary

 

                        None                                             

           

B.         Associated Companies

 

(1)   Zaka Health Care, Pakistan.

(2)   The Schazoo Pharmaceutical Laboratories, Pakistan.

(3)   Schazoo Zaka (Pvt) Ltd, Pakistan.

 

 

Products / Services

 

Manufacture & Marketing of Pharmaceutical Products by its brand names of BONE-CARE, CARTEX, CARTEX-H, CIPROL, CITRFAST, CYCLOSEN,

DOGREL, ETHOMID, FIOFEN, HESTIN, KOTIN, LEBRIN, LERBIN,

LIPIDIN, LODIPIN, LOTENSE, LOTENSE-H, NASARIN, NEOBUTINAL, NOPAIN, ORTHONATE, PAINCID, PERIMAC, PIOFIT, PIRODEX, PYRAZID, QUSPAR, RIFAPIN, RIFATOL, RIFAZOL PEDIATRIC, RIFAZOL+, SCHAZOBUTOL, SCHAZOBUTOL-H, SICHOR, SONTEL, SOPRAZOLE, TALOPRAM, TOMAX, TRIM FAST, UCAINE, VENTAIR, ZESPRA, ZETAB, ZOPROL

 

 

Number of Employees

           

165

 

 

Trade Suppliers (Foreign)

 

·         HARBIN NANO PHARMACEUTICAL & CHEM EQUIP CO. LTD, CHINA.

·         SHANGHAI SHAMROCK IMP & EXP CO., CHINA.

 

 

Annual Production Volume

 

The capacity and production of the company’s plant is indeterminable as it involves varying processes of manufacture.

 

 

Annual Sales Volume

 

Years

In Pak Rupees

2007

2008

340,856,265/-

407,679,999/-

 

 

Distributors Network

 

Mainly exist at all major cities of Pakistan

 

 

Bankers

 

·         The Bank of Punjab, Pakistan.

·         MCB Bank Limited, Pakistan.

·         Habib Bank Limited, Pakistan.

·         Bank Alfalah Limited, Pakistan.

·         Soneri Bank Limited, Pakistan.

 

 

 

Memberships

 

·         Lahore Chamber of Commerce & Industry.(LCCI)

·         Pakistan Pharmaceutical Manufacturers Association.(PPMA)

 

 

Foreign Exchange Rates

 

Currency

 

Unit

Pakistani Rupee

US Dollar

1

          Rs. 84.90

UK Pound

1

          Rs. 137.26 

Euro

1

          Rs. 120.74

 

 

Comments

 

Subject Company was established in 1952 and is engaged in manufacture & marketing of Pharmaceutical Products. Overall reputation is satisfactory. Trade relations are reported as fair. Company can be considered for normal business dealings at usual trade terms & conditions.

 

 

 

 

 

 

 

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.44.04

UK Pound

1

Rs.72.20

Euro

1

Rs.63.40

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.